Knowledge and News for the Global Fight Against Cancer.
Colorado-based Enveda Biosciences, a pioneering force in artificial intelligence-driven drug discovery, has successfully closed a...
The Rudensky Symposium on Immunity, Inflammation and Tolerance, held from August 27 to 28, 2026,...
Celldex Therapeutics’ experimental drug, barzolvolimab, has presented a complex picture to the biopharmaceutical world, demonstrating...
Amgen Inc. has announced that dazodalibep, a investigational therapy for Sjögren’s syndrome, has successfully met...
For many individuals navigating a cancer diagnosis, the immediate focus is often on survival and...
Cambridge, MA – September 22, 2026 – New data emerging from Viking Therapeutics’ Phase 2...
The U.S. Food and Drug Administration (FDA) has granted accelerated approval to Tudriqev (vusolimogene oderparepvec-wtpg,...
President Donald Trump’s "most-favored-nation" (MFN) agreements with pharmaceutical companies, purportedly designed to curb drug prices...
Seven years ago, the pharmaceutical landscape for depression underwent a significant shift when Johnson &...
In a significant advancement for ocular gene therapy and the treatment of rare inherited retinal...
admin